Natixis Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.7M | Buy |
102,188
+3,315
| +3% | +$651K | 0.02% | 524 |
|
|
2026
Q1 | $19.4M | Buy |
98,873
+1,871
| +2% | +$364K | 0.03% | 502 |
|
|
2025
Q4 | $16.8M | Sell |
97,002
-30,362
| -24% | -$5.53M | 0.02% | 534 |
|
|
2025
Q3 | $24.3M | Sell |
127,364
-1,718
| -1% | -$305K | 0.04% | 425 |
|
|
2025
Q2 | $23.2M | Buy |
129,082
+16,850
| +15% | +$2.93M | 0.04% | 423 |
|
|
2025
Q1 | $19M | Buy |
112,232
+8,257
| +8% | +$1.36M | 0.04% | 459 |
|
|
2024
Q4 | $15.7M | Buy |
103,975
+11,145
| +12% | +$1.73M | 0.03% | 522 |
|
|
2024
Q3 | $14.4M | Buy |
92,830
+6,619
| +8% | +$989K | 0.03% | 539 |
|
|
2024
Q2 | $11.8M | Buy |
86,211
+8,863
| +11% | +$1.21M | 0.03% | 555 |
|
|
2024
Q1 | $10.3M | Sell |
77,348
-3,253
| -4% | -$422K | 0.02% | 600 |
|
|
2023
Q4 | $11.1M | Buy |
80,601
+25,847
| +47% | +$3.4M | 0.03% | 531 |
|
|
2023
Q3 | $6.67M | Sell |
54,754
-16,873
| -24% | -$2.25M | 0.02% | 620 |
|
|
2023
Q2 | $10.1M | Buy |
71,627
+8,524
| +14% | +$1.18M | 0.03% | 526 |
|
|
2023
Q1 | $8.93M | Buy |
63,103
+11,410
| +22% | +$1.63M | 0.03% | 529 |
|
|
2022
Q4 | $8.09M | Buy |
51,693
+625
| +1% | +$89.8K | 0.03% | 539 |
|
|
2022
Q3 | $6.27M | Buy |
51,068
+3,618
| +8% | +$476K | 0.03% | 569 |
|
|
2022
Q2 | $6.31M | Sell |
47,450
-2,990
| -6% | -$407K | 0.03% | 584 |
|
|
2022
Q1 | $6.9M | Sell |
50,440
-394
| -0.8% | -$54.9K | 0.03% | 583 |
|
|
2021
Q4 | $8.79M | Buy |
50,834
+9,623
| +23% | +$1.46M | 0.03% | 501 |
|
|
2021
Q3 | $5.99M | Sell |
41,211
-2,123
| -5% | -$311K | 0.02% | 587 |
|
|
2021
Q2 | $5.72M | Buy |
43,334
+8,456
| +24% | +$1.11M | 0.03% | 593 |
|
|
2021
Q1 | $4.48M | Buy |
34,878
+2,068
| +6% | +$255K | 0.02% | 628 |
|
|
2020
Q4 | $3.91M | Sell |
32,810
-24,072
| -42% | -$2.93M | 0.02% | 647 |
|
|
2020
Q3 | $6.51M | Buy |
56,882
+4,152
| +8% | +$491K | 0.04% | 438 |
|
|
2020
Q2 | $6.01M | Sell |
52,730
-17,846
| -25% | -$1.89M | 0.04% | 448 |
|
|
2020
Q1 | $5.67M | Buy |
70,576
+8,031
| +13% | +$831K | 0.05% | 416 |
|
|
2019
Q4 | $6.68M | Buy |
62,545
+1,234
| +2% | +$129K | 0.05% | 430 |
|
|
2019
Q3 | $6.56M | Buy |
61,311
+3,663
| +6% | +$376K | 0.05% | 395 |
|
|
2019
Q2 | $5.87M | Buy |
57,648
+32,536
| +130% | +$3.13M | 0.05% | 409 |
|
|
2019
Q1 | $2.26M | Buy |
25,112
+11,594
| +86% | +$1M | 0.02% | 718 |
|
|
2018
Q4 | $1.13M | Sell |
13,518
-22,342
| -62% | -$2.09M | 0.01% | 874 |
|
|
2018
Q3 | $3.87M | Sell |
35,860
-300
| -0.8% | -$32.9K | 0.03% | 565 |
|
|
2018
Q2 | $3.98M | Sell |
36,160
-1,600
| -4% | -$167K | 0.04% | 543 |
|
|
2018
Q1 | $3.79M | Sell |
37,760
-4,252
| -10% | -$435K | 0.04% | 535 |
|
|
2017
Q4 | $4.14M | Buy |
42,012
+1,642
| +4% | +$156K | 0.04% | 482 |
|
|
2017
Q3 | $3.78M | Sell |
40,370
-6,581
| -14% | -$699K | 0.04% | 519 |
|
|
2017
Q2 | $5.22M | Sell |
46,951
-6,156
| -12% | -$651K | 0.06% | 406 |
|
|
2017
Q1 | $5.21M | Sell |
53,107
-8,293
| -14% | -$791K | 0.06% | 406 |
|
|
2016
Q4 | $5.64M | Buy |
61,400
+3,436
| +6% | +$296K | 0.07% | 364 |
|
|
2016
Q3 | $4.91M | Buy |
57,964
+2,336
| +4% | +$196K | 0.06% | 387 |
|
|
2016
Q2 | $4.53M | Sell |
55,628
-2,404
| -4% | -$183K | 0.06% | 391 |
|
|
2016
Q1 | $4.15M | Buy |
58,032
+10,111
| +21% | +$678K | 0.06% | 404 |
|
|
2015
Q4 | $3.41M | Buy |
47,921
+20,629
| +76% | +$1.39M | 0.06% | 444 |
|
|
2015
Q3 | $1.68M | Sell |
27,292
-14,138
| -34% | -$988K | 0.03% | 645 |
|
|
2015
Q2 | $3M | Sell |
41,430
-3,685
| -8% | -$272K | 0.05% | 502 |
|
|
2015
Q1 | $3.47M | Buy |
45,115
+21,750
| +93% | +$1.56M | 0.06% | 469 |
|
|
2014
Q4 | $1.57M | Buy |
23,365
+1,913
| +9% | +$121K | 0.03% | 677 |
|
|
2014
Q3 | $1.3M | Buy |
21,452
+2,648
| +14% | +$163K | 0.03% | 716 |
|
|
2014
Q2 | $1.1M | Buy |
18,804
+3,005
| +19% | +$176K | 0.02% | 794 |
|
|
2014
Q1 | $915K | Buy |
15,799
+11,138
| +239% | +$597K | 0.01% | 788 |
|
|
2013
Q4 | $250K | Sell |
4,661
-734
| -14% | -$43.5K | ﹤0.01% | 1062 |
|
|
2013
Q3 | $334K | Buy |
+5,395
| New | +$323K | 0.01% | 945 |
|
Other funds holding DGX
EIG
Natixis Advisors's DGX Position: Q2 2026 in Review
Natixis Advisors increased its Quest Diagnostics (DGX) stake by 3.4% in Q2 2026, buying an estimated $651K and bringing the position to 102,188 shares worth $21.7M. The position accounts for 0.02% of the portfolio, ranked #524.
Natixis Advisors first reported a position in DGX in Q3 2013 and has held it in 52 quarters since. The position peaked at $24.3M in Q3 2025. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Natixis Advisors held 102,188 shares of Quest Diagnostics worth $21.7M as of Q2 2026.
- Natixis Advisors bought 3,315 Quest Diagnostics shares in Q2 2026, an estimated $651K.
- Quest Diagnostics made up 0.02% of Natixis Advisors's portfolio in Q2 2026, its #524 holding.
- Natixis Advisors first reported a position in Quest Diagnostics in Q3 2013 and has held it in 52 quarters since.
- Natixis Advisors's Quest Diagnostics position peaked at $24.3M in Q3 2025.
- 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.